Abstract
Inflammatory bowel diseases (IBD) are chronic, idiopathic, polygenic diseases with significant genetic heterogeneity. The two major types of IBD are Crohn’s disease (CD) and ulcerative colitis (UlC). It is well known that chronic intestinal inflammation results from the interplay of genetic, immunologic, and environmental factors, so the failure to properly downregulate nonspecific inflammation started by an environmental trigger may lead to the development of IBD. Recent studies indicate several microRNAs (miRNAs) as regulators of important pathways of the immune response and immune cell development, which are crucial to the pathogenesis of a variety of inflammatory diseases, including IBD. Additionally, miRNAs are shown to be crucial regulators of intestinal epithelial barrier function, colonic epithelial cell-derived chemokine expression, and autophagy mechanisms. About 100 miRNAs have been indicated to exhibit altered expression in tissues and blood for UlC and CD, when compared to healthy normal controls. Taking into consideration that to date the diagnosis and follow-up of IBD are performed by invasive colonoscopy, it is well suggested that circulating microRNAs might be promising noninvasive biomarkers for IBD. Therefore, recent studies have focused on comparing miRNAs expression profile in tissue to miRNAs profile in blood, in order to introduce the analysis of circulating microRNAs in the future clinical practice. In this chapter, the role of microRNAs in IBD and the most promising circulating microRNAs will be discussed that could be used as noninvasive biomarkers for IBD diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams AT, Kennedy NA, Hansen R et al (2014) Two-stage genome-wide methylation profiling in childhood-onset Crohn’s Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis 20:1784–1793
Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246–252
Androulidaki A, Iliopoulos D, Arranz A et al (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220–231
Bazzoni F, Rossato M, Fabbri M et al (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106:5282–5287
Bian Z, Li L, Cui J et al (2011) Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 225:544–553
Brain O, Owens BM, Pichulik T et al (2013) The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity 39:521–536
Brant SR, Panhuysen CI, Nicolae D et al (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282–1292
Brest P, Lapaquette P, Souidi M et al (2011) A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet 43:242–245
Buchner AM, Blonski W, Lichtenstein GR (2011) Update on the management of Crohn’s disease. Curr Gastroenterol Rep 13:465–474
Chamaillard M, Iacob R, Desreumaux P et al (2006) Advances and perspectives in the genetics of inflammatory bowel disease. Clin Gastroenterol Hepatol 4:143–151
Chen CZ, Li L, Lodish HF et al (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–86
Chen Y, Ge W, Xu L et al (2012) miR- 200b is involved in intestinal fibrosis of Crohn’s disease. Int J Mol Med 29:601–606
Chen Y, Wang C, Liu Y et al (2013a) miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease. Biochem Biophys Res Commun 438:133–139
Chen Y, Xiao Y, Ge W et al (2013b) miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis 4:e541
Croxford AL, Mair F, Becher B (2012) IL-23: one cytokine in control of autoimmunity. Eur J Immunol 42:2263–2273
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463
Duttagupta R, DiRienzo S, Jiang R et al (2012) Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS ONE 7, e31241
Ek WE, D’Amato M, Halfvarson J (2014) The history of genetics in inflammatory bowel disease. Ann Gastroenterol 27:294–303
Escobar TM, Kanellopoulou C, Kugler DG et al (2014) miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity 40:865–879
Fasseu M, Tréton X, Guichard C et al (2010) Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with nflammatory bowel disease. PLoS ONE 5, e13160
Feng X, Wang H, Ye S et al (2012) Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS ONE 7, e52782
Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 40:710–712
Franchi L, Warner N, Viani K et al (2009) Function of Nod like receptors in microbial recognition and host defense. Immunol Rev 227:106–128
Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125
Ghorpade DS, Sinha AY, Holla S et al (2013) NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem 288:33037–33048
Gibbings D, Mostowy S, Jay F et al (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14:1314–1321
Huang Z, Shi T, Zhou Q et al (2014) miR-141 regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn’s disease. Gut 63:1247–1257
Hugot J-P, Chamaiilard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603
Iborra M, Bernuzzi F, Correale C et al (2013) Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 73:250–258
Jeker LT, Zhou X, Gershberg K et al (2012) MicroRNA 10a marks regulatory T cells. PLoS ONE 7, e36684
Jiang S, Li C, Olive V et al (2011) Molecular dissection of the miR-17-92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118:5487–5497
Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124
Kalla R, Ventham NT, Kennedy NA et al (2014) MicroRNAs: new players in IBD. Gut 64:504–517
Koukos G, Polytarchou C, Kaplan JL et al (2013) MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145:842–852e2
Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734
Li QJ, Chau J, Ebert PJ et al (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129:147–161
Lu LF, Thai TH, Calado DP et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30:80–91
Lu C, Chen J, Xu HG et al (2014) MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology 146:188–199
Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54e42
Muljo SA, Ansel KM, Kanellopoulou C et al (2005) Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202:261–269
Nata T, Fujiya M, Ueno N et al (2013) MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function. J Gene Med 15:249–260
Nguyen HT, Dalmasso G, Müller S et al (2014) Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146:508–519
Noble CL, Nimmo ER, Drummond H et al (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn’s disease. Gastroenterology 129:1854–1864
Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in Nod2 associated with susceptibility to Crohn’s disease. Nature 411:603–606
Paraskevi A, Theodoropoulos G, Papaconstantinou I et al (2012) Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 6:900–904
Parkes M, Cortes A, van Heel DA et al (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 14(9):661–673
Patel KK, Stappenbeck TS (2013) Autophagy and intestinal homeostasis. Annu Rev Physiol 75:241–262
Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3(7):390–407
Schulte LN, Westermann AJ, Vogel J (2013) Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res 41:542–553
Stoll M, Corneliussen B, Costello CM et al (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36:476–480
Tang B, Xiao B, Liu Z et al (2010) Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 584:1481–1486
Velu VK, Ramesh R, Srinivasan AR (2012) Circulating MicroRNAs as biomarkers in health and disease. J Clin Diagn Res 6:1791–1795
Westbrook AM, Szakmary A, Schiest RH (2010) Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res 705:40–59
Wu F, Zhang S, Dassopoulos T et al (2010) Identification of microRNAs associated with ileal and colonic Crohn’s disease. Inflamm Bowel Dis 16:1729–1738
Wu F, Guo NJ, Tian H et al (2011) Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 17:241–250
Wu F, Dong F, Arendovich N et al (2014) Divergent influence of microRNA-21 deletion on murine colitis phenotypes. Inflamm Bowel Dis 20:1972–1985
Xue X, Feng T, Yao S et al (2011) Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 187:5879–5886
Yang Y, Ma Y, Shi C (2013) Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun 434:746–752
Ye D, Guo S, Al-Sadi R et al (2011) MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141:1323–1333
Zahm AM, Thayu M, Hand NJ et al (2011) Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 53:26–33
Zahm AM, Hand NJ, Tsoucas DM et al (2014) Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. J Crohns Colitis 8:1108–1117
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gazouli, M. (2015). Circulating microRNAs in Inflammatory Bowel Diseases. In: Igaz, P. (eds) Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum, vol 106. Springer, Basel. https://doi.org/10.1007/978-3-0348-0955-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0955-9_9
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0953-5
Online ISBN: 978-3-0348-0955-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)